ArticleJournal of managed care & specialty pharmacy2017

Factors Associated with Adherence to and Treatment Duration of Erlotinib Among Patients with Non-Small Cell Lung Cancer.

Lisa M Hess et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.